Par CEO replaced
Executive Summary
Patrick LePore takes over as president and CEO of Par Pharmaceutical following resignation of Scott Tariff at the request of the board of directors, the company announces Sept. 26. Executive chairman Mark Auerbach also steps down at board's request; former lead director John Abernathy will fill the role as non-executive chairman. LePore worked in sales and marketing at Roche from 1978 to 1984; in 2002, he oversaw the sale of medical communications company Boron LaPore & Associates to Cardinal Health. Par announced in July that it would be restating its financial results for 2004 through the first quarter of 2006, reducing Par's revenues over that time period by as much as $55 mil...